The new report by Expert Market Research titled, ‘Global Generic Injectables Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global generic injectables market, assessing the market based on its segments like applications, containers, distribution channel and regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/generic-injectables-market/requestsample
The key highlights of the report include:
Market Overview (2016-2026)
- Historical Market Size (2020): USD 32 billion
- Forecast CAGR (2021-2026): 9.0%
- Forecast Market Size (2026): USD 54 billion
The global generic injectables market is being driven by the rising prevalence of cancer, cardiovascular disease, and other diseases around the world, as well as increased demand for drugs to help patients undergoing chemotherapy manage side effects like pain. The oncology sector, among other applications, dominates the market, accounting for a large portion of the total. Hospitals have the largest market share among the different distribution networks.
North America is the most important region, accounting for more than half of the global share. The availability of advanced technologies and strengthened healthcare infrastructure in the region has led to the it’s growth in the global generic injectables market. The Asia Pacific, on the other hand, is projected to be one of the emerging markets due to increased government spending in the healthcare sector and the emergence of a massive population.
Industry Definition and Major Segments
Generic injectables are non-patentable injectables that are bioequivalent to their branded equivalents. They are safe and reliable, and they are close to the original drugs. They have the same active ingredients, dose, consistency, and strength as their original counterparts, and thus perform similarly in terms of performance, intended usage, quality, shape, and route of administration to their original counterparts.
Explore full report with table of contents: https://www.expertmarketresearch.com/reports/generic-injectables-market
On the basis of applications, the industry is bifurcated into:
- Oncology
- Anaesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular
- Others
Based on containers, the industry is segmented into:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
- Others
Basis distribution channel, the industry can be further divided into:
- Hospitals
- Retail Pharmacy
The regional markets for Ghee include:
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa
Market Trends
The rising prevalence of chronic, deadly, and lifestyle diseases around the world, as well as the high costs associated with their cure, are driving the global generic injectables market. These medications are bioequivalent to brand-name medicines and are used as a substitute for them in the treatment of different diseases, having similar pharmacological results. When the number of patients increase, so does the use of generic injectables. They save time and offer instant relief as they are directly injected into the bloodstream.
While generic injectables are more difficult to produce, their research and development costs are lower and take less time. Unlike branded drug firms, generic drug companies do not have to spend significantly in product creation and marketing. The demand for these injectables has risen as overall healthcare costs have risen sharply. Furthermore, the global generic injectables market is benefiting from the increasing preference for generic oncology drugs for treating cancer patients. The industry is being aided even more by the increasing geriatric population and growing demand for cost-effective treatment procedures, especially in emerging regions.
Also, an increase in drug shortages, especially in the United States, as well as the patent expiration of several useful and well-known drugs, is boosting the global generic injectables sector. The market’s growth is being aided by increased research and development activities. To meet increasing customer demand, the market’s leading players are innovating and releasing improved products. Over the forecast period, manufacturers’ production of new formulations is expected to have a positive impact on the global generic injectables market.
Key Market Players
The major players in the market are Fresenius Kabi, Hikma Pharmaceuticals PLC, Sagent Pharmaceuticals Inc., Sanofi, Sandoz (Novartis) and Others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
About Us:
Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
Media Contact
Company Name: Claight Corporation
Contact Person:-Ian Bell, Business Consultant
Email: [email protected]
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
**We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
Several top players in the generic injectables market are focusing on mergers and acquisitions to consolidate their shares.
They are also making substantial investment in research and development activities with an aim to develop new products, in order to gain an edge over their competitors, notes Transparency Market Research (TMR).
Some of the companies holding leading positions in the market are Biocon Limited, Sanofi, Lupin Ltd., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius SE & Co. KGaA, Baxter, Novartis AG (Sandoz International GmbH), and Pfizer Inc.A growing number of producers of generic injectables are focusing on products that meet the highest standard of efficacy and safety as that of the originator products.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=42698The global generic injectables market is projected to expand rapidly from its worth of US$ 49.0 billion in 2016 to reach a worth of over US$ 150 billion by 2025.
This represents a robust CAGR of nearly 13.6% during the forecast period of 2017–2025.The various product types can be grouped into ampoules, vials, premixes, and prefilled syringes.
Of all the segments, the market for prefilled syringes is expected to rise at the most attractive CAGR during the assessment period.
The higher precision of dose, ease of self-administration, and reduced wastage of products are some of the compelling benefits accounting for their widespread acceptance.Regionally, Asia Pacific led the global market in 2016 with substantial uptake of generic injectables among patient populations.
The global generic injectables market is expected to exhibit a solid 13% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).
The global generic injectables market is mainly driven by the growing prevalence of noncommunicable diseases, which are mainly treated by injectables.
The increasing prevalence of flu and other seasonal maladies has been a major driver for the generic injectables market.
The growing effects of climate change are making seasonal maladies more severe, as more severe allergens and pathogens are being thrown up into the mix due to the shakeup caused by climate change.
The increasing prevalence of cancer, AIDS, and other noncontagious diseases is also likely to be a major driver for the global generic injectables market over the forecast period.Competitive Analysis:Leading players in the global generic injectables market include Novartis AG, Baxter, Fresenius SE & Co. KGaA, Mylan NV, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals plc, Sanofi, Biocon, Reddy’s Laboratories, Aurobindo Pharma, Zydus Cadila, GSK plc, and AstraZeneca plc.
Generic injectables and biosimilar APIs will be the company’s main focus in the coming months.
Generic Injectables Market Research Report, by Product Type (Monoclonal antibodies, Cytokines, Insulin, Vaccines), Container (Vials, Ampoules, Premix, Prefilled syringes), Application (Oncology, Anaesthesia, Anti-infectives, Cardiovascular), Distribution Channel (Hospital pharmacy, Retail pharmacy, Drug stores, Online stores) – Global Forecast Till 2027The global generic injectables market is expected to exhibit a solid 13% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).
The global generic injectables market is mainly driven by the growing prevalence of noncommunicable diseases, which are mainly treated by injectables.
The increasing prevalence of flu and other seasonal maladies has been a major driver for the generic injectables market.
The growing effects of climate change are making seasonal maladies more severe, as more severe allergens and pathogens are being thrown up into the mix due to the shakeup caused by climate change.
The increasing prevalence of cancer, AIDS, and other noncontagious diseases is also likely to be a major driver for the global generic injectables market over the forecast period.
The use of generic injectables for treating cancer, in particular, is growing and is likely to play a key role in the global generic injectables market’s growth in the coming years.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7512 Growing research and drug development initiatives from government as well as nongovernmental medical research institutions is also likely to be a major driver for the global generic injectables market over the forecast period.
The Global Generic Injectables Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.DriversAging population and rising prevalence of chronicTechnological advancementRestraintsInfections associated with needle stick injuriesThe comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on therapeutic area and distribution channel.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Browse the complete Global Generic Injectables Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/20903-generic-injectables-market-reportThe report also covers the complete competitive landscape of the global Generic Injectables market with company profiles of key players such as:Baxter International Inc.Fresenius KabiHikma PharmaceuticalsNovartis International AGPfizer Inc.Sagent PharmaceuticalsSanofi S.A.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Therapeutic Area:OncologyAnaesthesiaAnti-InfectivesParenteral NutritionCardiovascularOthersBy Distribution Channel:HospitalsRetail Pharmacy StoresBy Geography:North America (NA) – US, Canada & Rest of North AmericaEurope (EU) – UK, Germany, France & Rest of EuropeAsia Pacific (APAC) – China, Japan, India & Rest of APACLatin America (LA) – Brazil & Rest of Latin AmericaMiddle East & Africa (MEA) – Middle East and AfricaDownload Free Sample Report of Global Generic Injectables Market @ https://www.decisiondatabases.com/contact/download-sample-20903The Global Generic Injectables Market has been exhibited in detail in the following chapters -Chapter 1 Generic Injectables Market PrefaceChapter 2 Executive SummaryChapter 3 Generic Injectables Industry AnalysisChapter 4 Generic Injectables Market Value Chain AnalysisChapter 5 Generic Injectables Market Analysis By Therapeutic AreaChapter 6 Generic Injectables Market Analysis By Distribution ChannelChapter 7 Generic Injectables Market Analysis By GeographyChapter 8 Competitive Landscape Of Generic Injectables CompaniesChapter 9 Company Profiles Of Generic Injectables IndustryPurchase the complete Global Generic Injectables Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-20903Other Reports by DecisionDatabases.com:Global Needle Free Injection Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Auto-Injectors Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Contrast Media Injectors Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
